Axsome Therapeutics Initiates Phase 2 Trial of AXS-05 in Major Depressive Disorder Pharmaceutical Investing
Isodiol International Inc. Completes Acquisition of Farmtiva Inc. for 51% Ownership and Completes First Planting of Farm Bill Compliant Hemp in California Cannabis Investing News
Kite Announces Initial Results From a Phase 1 Study of T Cell Receptor (TCR) Cell Therapy in HPV-16-Positive Solid Tumors Pharmaceutical Investing
Opdivo (nivolumab) 3 mg/kg Demonstrates Sustained, Superior Recurrence-Free Survival Versus Yervoy (ipilimumab) 10 mg/kg for Broad Range of Patients with Resected Stage III or IV Melanoma Pharmaceutical Investing
Merck’s KEYTRUDA (pembrolizumab) Demonstrated Long-Term Survival Benefit Based on Four and Five Years of Follow-Up from Two Pivotal Studies in Advanced Melanoma Pharmaceutical Investing
Alnylam Receives Orphan Drug Designation from the United States Food & Drug Administration for ALN-TTRsc02 Pharmaceutical Investing
